Clinical Trials Browser

Terminated × NIH × Prostatic Neoplasms × Clear all

NCT04616547 2025-10-03

Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to Bones

Phase 2 Terminated

1 enrolled 8 charts

Prostatic Neoplasms

NCT05872503 2025-07-10

Study of Rates of Prostate Cancer Diagnosis in Men of African Ancestry Using MRI and MRI Guided Biopsy

Prostatic Neoplasms

NCT01231932 2025-06-19

Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors

BreastGenitourinary

Breast Neoplasms, Fatigue, Neoplasms, Prostatic Neoplasms

NCT00019695 2024-03-04

Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer

Phase 2 Terminated

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms, Genetic Diseases, Inborn

NCT02203513 2022-09-10

A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer

Phase 2 Terminated

111 enrolled 15 charts

BreastGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT03531827 2022-07-12

Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment

Phase 2 Terminated

4 enrolled 12 charts

Prostatic Neoplasms

NCT02362451 2022-03-18

Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer

Phase 2 Terminated

7 enrolled 10 charts

Prostatic Neoplasms

NCT03478904 2021-05-10

Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer

Phase 1 Terminated

1 enrolled 8 charts

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT00124917 2019-09-13

Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer

Phase 1 Terminated

6 enrolled 9 charts

Prostatic Neoplasms

NCT01445054 2019-03-11

111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer

Phase EARLY_PHASE1 Terminated

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Prostatic Neoplasms

NCT01163084 2019-02-28

Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer

Phase 1/2 Terminated

10 enrolled 7 charts

Prostatic Neoplasms

NCT00527124 2018-08-09

Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2 Terminated

57 enrolled 12 charts

Prostatic Neoplasms

NCT01200810 2017-12-02

Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer

Phase 2 Terminated

10 enrolled 7 charts

Prostatic Neoplasms

NCT01145508 2017-09-19

Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase 2 Terminated

10 enrolled 6 charts

Prostatic Neoplasms

NCT01267266 2015-04-01

Saracatinib in Treating Patients With Prostate Cancer

Phase 2 Terminated

31 enrolled 6 charts

Prostatic Neoplasms

NCT00058214 2015-02-23

Perifosine in Treating Patients With Recurrent Prostate Cancer

Phase 2 Terminated

25 enrolled 5 charts

Prostatic Neoplasms

NCT00005075 2013-11-06

Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer

Phase 3 Terminated

Prostatic Neoplasms

NCT00005039 2013-01-24

Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer)

Phase 2 Terminated

Prostatic Neoplasms

NCT00005067 2013-01-16

Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer

Phase 1 Terminated

Prostatic Neoplasms

NCT00512668 2013-01-07

Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer

Phase 1 Terminated

Prostatic Neoplasms